Viewing Study NCT04961359


Ignite Creation Date: 2025-12-24 @ 2:35 PM
Ignite Modification Date: 2025-12-26 @ 4:23 AM
Study NCT ID: NCT04961359
Status: COMPLETED
Last Update Posted: 2023-04-25
First Post: 2021-07-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2(COVID-19) Phase I Clinical Trial (3~17 Years Old)
Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module